Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
about
Notch signaling induces rapid degradation of achaete-scute homolog 1.The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-MycFAT10, a ubiquitin-independent signal for proteasomal degradationPim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cellsSelective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosisNegative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1).A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasomeN-terminal polyubiquitination and degradation of the Arf tumor suppressorN-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasomeRegulation of the 26S proteasome by adenovirus E1APolyamines in spermiogenesis: not now, darlingDown-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cellsThe cytoplasmic Hsp70 chaperone machinery subjects misfolded and endoplasmic reticulum import-incompetent proteins to degradation via the ubiquitin-proteasome systemRapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiationThe Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimerStable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation controlProteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28 -Dependent MechanismExamination of the expanding pathways for the regulation of p21 expression and activity.Yeast antizyme mediates degradation of yeast ornithine decarboxylase by yeast but not by mammalian proteasome: new insights on yeast antizyme.RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit.Activation of the cyclin-dependent kinase CTDK-I requires the heterodimerization of two unstable subunits.The C-terminal residues of Saccharomyces cerevisiae Mec1 are required for its localization, stability, and function.Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degronLens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integraseCDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiationReversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathwaysProteasome-mediated degradation of the coactivator p300 impairs cardiac transcriptionA novel, non-apoptotic role for Scythe/BAT3: a functional switch between the pro- and anti-proliferative roles of p21 during the cell cycleFates of retroviral core components during unrestricted and TRIM5-restricted infectionAn HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesisNF-kappaB dictates the degradation pathway of IkappaBalphaThe E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.p21 in cancer: intricate networks and multiple activitiesH2AX is required for cell cycle arrest via the p53/p21 pathwayEpstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene BimCDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.
P2860
Q24293622-3A86E2B2-23D7-453B-A18C-795F7DCE17FDQ24299799-307D09C0-358B-4F92-8B4D-7F331199F9FCQ24300071-7D4C96E8-FD29-4361-85FF-EE36D1FB08CBQ24304170-A7E4E62D-C632-4DCF-9760-4A3FEB9ED2F9Q24305063-4230CFC6-6BE4-4E0B-AB0A-44C4BE3A3E9DQ24307639-421E7824-9CFE-46F3-8E7C-6C24E50C044EQ24338676-47F99181-4252-43A3-8060-C39EA4BD49FEQ24534132-BCC3F871-6D8D-45E3-A80B-897C8B595318Q24535198-508DFC1C-61A2-48E7-849D-A456C0CF98D8Q24561681-21B6B926-AE7F-4697-BB03-DC32BE618FE8Q24563960-6F240F69-EC0D-414C-B0F5-B5E309136258Q24599178-494A7984-92F6-4353-BCEC-2C2797F1C5C9Q24609291-97F1E970-3CB3-4CAB-98DE-6C74C4C4F7FAQ24672087-05979958-FD5F-4E9C-B296-D08315CD8C27Q24676115-5A0211D5-7B82-4DF3-BA98-B7D58F6E9925Q24683060-D6201B1B-4288-497E-A2BB-8C52087030D9Q24685712-F6EA1AE1-6A43-4F64-88B9-FAC6B2AD4525Q25255281-8382351D-9F15-4E1F-9F3D-56637DAFE758Q27487945-62FB0516-ED23-4709-959F-F15907D3C5F0Q27692024-24E4C162-FC79-46A8-B33C-3546DEAB28BAQ27933448-01A4430C-7ABC-4F6E-A648-E557FB098388Q27933746-C93619E5-F679-4752-9496-97699DBC825DQ27936458-F51307D5-EACF-41FE-B57C-6830E54DBBF5Q27937771-C620EE44-4D1C-4BAA-8ED6-EE39268B9381Q28205086-48844F69-E8E0-47CC-ABED-962410773D00Q28261724-871E13D5-64A0-471D-9C93-F9A984D28502Q28287194-F252E421-E3D0-4350-AB4C-C79065901943Q28290857-32899142-F4AE-4CAA-9AB4-86B2295082ECQ28306744-D8DFFA57-DE5C-474C-9B80-5C8512018783Q28344911-B960783F-9221-4A21-B1EB-C244D9AA8A26Q28385780-99B1929C-49F1-4BF9-A277-481E43766478Q28487732-AD074DEE-F6C7-4317-94F7-1B31CADBACFEQ28506446-3B86DC3B-66CF-41D2-847C-A5137B093A8DQ28588231-AB2E90D6-9ADA-459F-9CB6-B56CAD7D85DEQ30268527-FDD057DC-2737-4F23-A5DB-38E8AAC71F61Q30436015-C17C3E4C-7081-4D02-B118-75BD62EE956DQ30487614-0EA0FD72-A9B0-4A9D-99D5-2F516BD800D3Q33474807-0C2BC2B5-49CD-4BDE-BC29-71175F3A03D1Q33529367-A4759EDD-AC60-43A9-B6F3-9D1209ABD3A2Q33648313-57E0BFBF-22EF-4826-92C4-EE42ADA6BB94
P2860
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@ast
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@en
type
label
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@ast
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@en
prefLabel
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@ast
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@en
P2093
P1433
P1476
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
@en
P2093
Clurman BE
Roberts JM
Smitherman M
P304
P356
10.1016/S1097-2765(00)80435-9
P577
2000-02-01T00:00:00Z